drugset / Trial / NCT02424318

Topiramate and Cerebrovascular Response in Migraineurs

NCT02424318

Phase 4 Completed 19 enrolled SMG-SNU Boramae Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of topiramate on cerebrovascular reactivity and mean flow velocity to photic stimulation in migraineurs.

Timeline

Start
2008-12
Primary completion
2009-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 50 mg

Indications